How HCA Healthcare’s (HCA) Advanced Therapy Research Highlights Its High-Acuity Care Capabilities
HCA Healthcare, Inc. (NYSE:HCA) is one of the best medical care facilities stocks to buy according to analysts. The company ranks tenth on the list, with analysts seeing roughly 21.9% upside on average. The latest relevant development was clinical rather than purely financial: on June 29, HCA Healthcare announced new research published in The New England Journal of Medicine involving gene-editing therapy being studied in children ages 5 to 11 with severe sickle cell disease and transfusion-dependent beta t ...